The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative ...
Mar 18, 2019
0
4
In the year following placement of a CardioMEMS heart failure sensor—designed to wirelessly measure and monitor pulmonary artery pressures that can signal worsening heart failure—patients experienced a 58 percent reduction ...
Mar 18, 2019
0
1
Late-breaking results from the ElectroCRT trial presented today at EHRA 2019 a European Society of Cardiology (ESC) congress, pave the way for a new standard of care to improve the heart's pump function in selected patients ...
Mar 18, 2019
0
1
Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction (HFpEF), a condition that ...
Dec 19, 2018
0
3
Acute heart failure patients with 'metabolically healthy obesity' have better survival than those with 'metabolically unhealthy obesity' or with normal weight regardless of metabolic status, according to a study presented ...
Dec 6, 2018
0
0
New research suggests that curcumin, a main ingredient in curry, may improve exercise intolerance related to heart failure. The study is published ahead of print in the Journal of Applied Physiology.
Nov 29, 2018
0
4
Heart failure patients fall into two general categories: those with weaker hearts, and those with stronger, but stiffer hearts that continue to eject the normal volume of blood with every beat. Although their hearts have ...
Nov 20, 2018
0
0
A team led by a Cedars-Sinai physician-scientist has discovered a biomarker—a protein found in the blood—for the most common type of heart failure, a new study published today in JAMA Cardiology shows.
Oct 31, 2018
0
18
A new University at Buffalo study has shown for the first time that walking more can significantly lower the risk of heart failure in older women.
Sep 5, 2018
0
13
The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and ...
Aug 27, 2018
0
0
